Company Quick10K Filing
Haemonetics
10-Q 2020-06-27 Filed 2020-08-04
10-K 2020-03-28 Filed 2020-05-20
10-Q 2019-12-28 Filed 2020-02-04
10-Q 2019-09-28 Filed 2019-11-01
10-Q 2019-06-29 Filed 2019-08-06
10-K 2019-03-30 Filed 2019-05-22
10-Q 2018-12-29 Filed 2019-02-05
10-Q 2018-09-29 Filed 2018-11-06
10-Q 2018-06-30 Filed 2018-08-07
10-K 2018-03-31 Filed 2018-05-23
10-Q 2017-12-30 Filed 2018-02-06
10-Q 2017-09-30 Filed 2017-11-07
10-Q 2017-07-01 Filed 2017-08-07
10-K 2017-04-01 Filed 2017-05-24
10-Q 2016-12-31 Filed 2017-02-06
10-Q 2016-10-01 Filed 2016-11-07
10-Q 2016-07-02 Filed 2016-08-01
10-K 2016-04-02 Filed 2016-06-01
10-Q 2015-12-26 Filed 2016-02-02
10-Q 2015-09-26 Filed 2015-11-04
10-Q 2015-06-27 Filed 2015-07-30
10-K 2015-03-28 Filed 2015-05-22
10-Q 2014-12-27 Filed 2015-02-05
10-Q 2014-09-27 Filed 2014-11-04
10-Q 2014-06-28 Filed 2014-07-31
10-K 2014-03-29 Filed 2014-05-22
10-Q 2013-12-28 Filed 2014-01-30
10-Q 2013-09-28 Filed 2013-10-30
10-Q 2013-06-29 Filed 2013-08-02
10-K 2013-03-30 Filed 2013-05-20
10-Q 2012-12-29 Filed 2013-02-01
10-Q 2012-09-29 Filed 2012-11-07
10-Q 2012-06-30 Filed 2012-08-08
10-K 2012-03-31 Filed 2012-05-22
10-Q 2011-12-31 Filed 2012-02-06
10-Q 2011-10-01 Filed 2011-11-03
10-Q 2011-07-02 Filed 2011-08-10
10-K 2011-04-02 Filed 2011-05-26
10-Q 2011-01-01 Filed 2011-02-08
10-Q 2010-10-02 Filed 2010-11-10
10-Q 2010-07-03 Filed 2010-08-11
10-K 2010-04-03 Filed 2010-06-01
10-Q 2009-12-26 Filed 2010-02-03
8-K 2020-08-04 Earnings, Exhibits
8-K 2020-07-21 Officers, Shareholder Vote, Regulation FD, Exhibits
8-K 2020-07-02 Regulation FD
8-K 2020-07-01 Regulation FD
8-K 2020-06-29 Regulation FD
8-K 2020-06-29 Shareholder Rights, Amend Bylaw, Regulation FD, Exhibits
8-K 2020-06-11
8-K 2020-05-28
8-K 2020-05-05
8-K 2020-04-16
8-K 2020-02-27
8-K 2020-02-04
8-K 2020-01-13
8-K 2019-11-01
8-K 2019-08-26
8-K 2019-08-06
8-K 2019-07-25
8-K 2019-07-22
8-K 2019-05-21
8-K 2019-05-14
8-K 2019-05-07
8-K 2019-04-23
8-K 2019-02-05
8-K 2018-12-19
8-K 2018-11-06
8-K 2018-08-07
8-K 2018-07-26
8-K 2018-06-18
8-K 2018-06-14
8-K 2018-05-08
8-K 2018-02-06
8-K 2018-01-24

Haemonetics Financials

HAE Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Dentsply Sirona (XRAY) 11,909 52% 27.4 2% 8,367 3,308 3,977 2,079 162 477 13,086
Insulet (PODD) 10,214 66% 201.9 1% 1,268 1,118 694 457 17 53 10,780
ABIOMED (ABMD) 8,562 83% 28.3 20% 1,124 133 820 679 221 297 8,412
Novocure (NVCR) 7,902 73% -778.8 -6% 444 253 322 235 -27 -10 7,842
Hill-Rom Holdings (HRC) 7,085 49% 27.4 3% 4,919 3,346 2,907 1,425 152 298 8,166
Haemonetics (HAE) 6,479 47% 39.1 6% 1,191 607 988 465 68 172 6,738
Integra Lifesciences (IART) 5,281 63% 33.0 2% 3,347 1,962 1,506 944 60 181 5,962
Globus Medical (GMED) 5,230 77% 24.0 10% 1,452 113 770 592 146 211 5,063
Penumbra (PEN) 4,900 67% 90.7 7% 614 147 523 353 45 53 4,788
Nuvasive (NUVA) 3,895 72% 27.0 3% 1,840 1,146 831 48 161 4,347
Tandem Diabetes Care (TNDM) 3,612 53% -179.8 -8% 293 126 330 175 -24 -19 3,455
ICU Medical (ICUI) 3,368 38% 21.1 4% 1,638 297 1,291 492 73 144 3,031
Cantel Medical (CMD) 3,193 46% 39.1 2% 1,906 1,174 950 438 42 103 4,044
Nevro (NVRO) 2,616 69% -31.3 -22% 448 250 384 263 -100 -87 2,724
Glaukos (GKOS) 2,258 87% -139.9 -6% 307 117 225 195 -19 -16 2,210
iRhythm Technologies (IRTC) 1,965 75% -37.6 -17% 310 167 198 150 -52 -49 1,841
Merit Medical Systems (MMSI) 1,715 44% 20.9 1% 1,762 812 970 425 19 101 2,119
Cardiovascular Systems (CSII) 1,707 81% 2,402.7 -1% 217 75 256 206 -3 1 1,648
Inspire Medical Systems (INSP) 1,606 82% -58.5 -16% 183 37 72 59 -29 -27 1,582
Atrion (ATRI) 1,554 35% 29.6 14% 257 24 156 55 36 50 1,490

Balance Sheet ($MM)2010-07-032010-10-022011-01-012011-04-022011-07-022011-10-012011-12-312012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272014-12-272015-03-282015-06-272015-09-262015-12-262016-04-022016-07-022016-10-012016-12-312017-04-012017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-292019-03-302019-06-292019-09-28
Cash83115170197217183205229236187193179166159178192140130125161112100105115118139130140172204252180192200155169190112
Accounts Receivable115122120127121129127135126158167170156162150165157151144146139145149157150152151153152144147151151162168185163177
Inventory8586828495101108117127174180184197205209198207209212211211208204187189195188177174169159161175164169194222245
PP&E451469474476485490497511518591620633641663676702294312323732329328333786340340336807322320330873316345351933277264
Assets6987387838338538248489119281,4551,4741,4621,4801,4841,4881,5141,4771,4751,4741,4851,4271,4191,3361,3191,3171,3351,3061,2391,2511,2711,3121,2371,2411,2661,2281,2751,2601,191
Accounts Payable2322202828302935344353504845435455444748424240403742494339424155655863636157
Long-Term Debt111612546645482482480481464447440431429429430429429422408400389337316303287270254348344344350436371
Liabilities133143135147141145143179171683695693705688663676662654640659636642617598602586536499479470489485567564585607669607
Stockholders' Equity565594649686712678705733757772779769774796825838815821834826792777720722716749771740773801823752674701643668591584
Income Statement ($MM)2010-07-032010-10-022011-01-012011-04-022011-07-022011-10-012011-12-312012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272014-12-272015-03-282015-06-272015-09-262015-12-262016-04-022016-07-022016-10-012016-12-312017-04-012017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-292019-03-302019-06-292019-09-28
Revenue163167177170171179191187176218247250220236242241224228232226213220233242210220228228211225234234229242247249238253
Cost of Revenue777983838289959286116134127108116120126118119120118111114125153119116127146119121123129146130136138123126
Gross Profit8688938889909695901021131231111201221151061081121081031051098991104101829210511110483112111111116127
R&D888991199911111411161414151111171112111111889881211999977
SG&A54535750566361656881878810782908793888374887579768871717367739879697774797370
Tax688775754434140-322-01324-40234-83371647238
Net Income18212021171418181071013-8171610-4716-3-013-59-9-102015-512020-712-3191821-837
Cash Flow ($MM)2010-07-032010-10-022011-01-012011-04-022011-07-022011-10-012011-12-312012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272014-12-272015-03-282015-06-272015-09-262015-12-262016-04-022016-07-022016-10-012016-12-312017-04-012017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-292019-03-302019-06-292019-09-28
Cash Operating14314732272529341332428132945511431275592832533139553538596558235721330
Cash Investing-15-9-17-11-12-12-13-16-9-561-14-12-36-24-16-31-37-33-30-22-27-26-24-28-22-19-17-15-4-15-26-18-27-48-1326
Cash Financing-5582544-466516479-4-2910-13-11-6-29-7-03-30-14-3-16-50-45-10-4-138-11319-0716-113